MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Applied Biologics

News headline image
Applied Biologics Receives Service-Disabled Veteran-Owned Small Business Certification
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Launches APPB-429 Gene Therapy Program for Diabetic Peripheral Neuropathy
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Welcomes New CMS RAPID Pathway and Expanded CMS-FDA Coordination for Innovative Medical Technologies
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Acceptance of Updated CAMPX XWRAP® Clinical Trial Results for Presentation at SAWC Fall 2026
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics CEO and Former Marine F/A-18 Pilot Edward Britt Selected as Honorary Commander at Luke Air Force Base
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Welcomes CMS’ Continued Commitment to Clinical Evidence in Advanced Wound Care
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Launches National Health System Partnership Initiative
From Applied Biologics
Via GlobeNewswire
News headline image
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Expands National Commercial Payer Engagement Strategy for XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Submission of XWRAP® Translational Research Abstract for Consideration at SAWC Fall 2026
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Introduces ECM Preservation Technology™ as the Proprietary Manufacturing Platform Behind XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces VA Federal Supply Schedule Contract Modification Supporting Long-Term Access to XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Expanded Strategic Focus on Surgical Applications of XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces National Commercial Expansion to Support Continued Growth of XWRAP® and Future Biologic Product Pipeline
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Completion of Translational Research Supporting the Biologic Performance of XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Submission of Abstract of Single-Layer Amniotic Membrane Plus Standard of Care for Chronic Diabetic Foot Ulcers: An Updated Analysis of The Campx Trial to SAWC Fall 2026
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Announces Completion of Planned Enrollment Activities in the CAMPX Randomized Controlled Trial Evaluating XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Reports Statistically Significant Improvement in Wound Closure Outcomes in Updated Analyses of the CAMPX Randomized Controlled Trial Evaluating XWRAP®
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Launches Preclinical Development Program Focused on Osteoarthritis and Other Degenerative Diseases
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Presents Interim CAMPX Clinical Trial Data at the Symposium on Advanced Wound Care (SAWC) Spring 2026
From Applied Biologics
Via GlobeNewswire
News headline image
Applied Biologics Receives FDA Clearance to Advance BIOxHEAL Into Phase 3 Clinical Development for Diabetic Foot Ulcers
From Applied Biologics
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story